Measuring Protein Thermal Stability and Phosphorylation Changes to Capture Early Cellular Responses to Small Molecule Drugs
Simultaneous CETSA® And Phosphoproteomics Profiling
CETSA® experiments have been performed in compressed format (also known as one-pot or PISA) After short (60 minutes) incubation of cells with different compounds, cell suspensions were divided into aliquots, followed by heat shock treatment (44–66 °C) for 3 minutes. After heat treatment, the samples were pooled back together followed by centrifugation to remove aggregated proteins. Proteins were digested and labelled with TMTpro (16plex). For the Phosphoproteomics analysis phosphopeptides were enriched using titanium dioxide resin.
- Both target engagement (CETSA®) and cellular signalling (phosphoproteomics) capture early cellular responses to treatment with small molecule drugs
- Changes in binding specificity translates into change in downstream phosphorylation events
- Parallel CETSA® and Phosphoproteomics analysis provides most comprehensive data on specificity and MoA of kinase inhibitors
Download our CETSA® and Phosphoproteomics analysis poster.
- Martinez Molina, D. et al. Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay. Science 341, 84-87 (2013)
- Savitski M. M., Reinhard F. B. M., Franken H., Werner T., Savitski M. F., Eberhard D., et al. (2014). Tracking Cancer Drugs in Living Cells by Thermal Profiling of the Proteome. Science 346 (6205), 1255784.
- Gaetani M., Sabatier P., Saei A. A., Beusch C. M., Yang Z., Lundström S. L., et al. (2019). Proteome Integral Solubility Alteration: A High-Throughput Proteomics Assay for Target Deconvolution. J. Proteome Res. 18 (11), 4027–4037.
- Friman at al., SLAS Discovery 2021, DOI: 10.1177/2472555220973597
- Chernobrovkin at al., SLAS Discovery 2021, DOI: 10.1177/2472555220984372
- Hendricks at al., ACS Chem. Biol. 2022, DOI: 10.1021/ acschembio.1c00488